{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:36:44Z","timestamp":1783478204522,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmc.2026.118633","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:12:16Z","timestamp":1773504736000},"page":"118633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy"],"prefix":"10.1016","volume":"137","author":[{"given":"Xue","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmc.2026.118633_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.bmc.2026.118633_bb0010","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2147\/NDT.S371483","article-title":"Rett syndrome and MECP2 duplication syndrome: disorders of MECP2 dosage","volume":"18","author":"Collins","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"10.1016\/j.bmc.2026.118633_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","article-title":"Global prevalence of Rett syndrome: systematic review and meta-analysis","volume":"12","author":"Petriti","year":"2023","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.bmc.2026.118633_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"6","key":"10.1016\/j.bmc.2026.118633_bb0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann Neurol"},{"issue":"suppl 1","key":"10.1016\/j.bmc.2026.118633_bb0030","first-page":"71","article-title":"Rett syndrome: analysis of deaths in the British survey","volume":"6","author":"Kerr","year":"1997","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.bmc.2026.118633_bb0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpeds.2005.10.037","article-title":"Rett syndrome in Australia: a review of the epidemiology","volume":"148","author":"Laurvick","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.bmc.2026.118633_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: from mouse models to human therapies","volume":"30","author":"Vashi","year":"2019","journal-title":"Mamm Genome"},{"issue":"13","key":"10.1016\/j.bmc.2026.118633_bb0045","first-page":"1142","article-title":"Trofinetide receives FDA approval as first drug for Rett syndrome","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2026.118633_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2008.12.003","article-title":"NNZ-2566: a Gly-pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke","volume":"278","author":"Bickerdike","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bmc.2026.118633_bb0055","unstructured":"US Food and Drug Administration. Highlights of prescribing information: DAYBUE (trofinetide) oral solution. Accessed July 12, 2023. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217026s000lbl.pdf."},{"issue":"16","key":"10.1016\/j.bmc.2026.118633_bb0060","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bmc.2026.118633_bb0065","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2026.118633_bb0070","doi-asserted-by":"crossref","unstructured":"Moore, R., Poulsen, J., Reardon, L. et al. Managing gastrointestinal symptoms resulting from treatment with Trofinetide for Rett syndrome: caregiver and nurse perspectives. Adv Ther. 2024; 41:1305\u20131317.","DOI":"10.1007\/s12325-024-02782-4"},{"key":"10.1016\/j.bmc.2026.118633_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41573-022-00529-w","article-title":"Derivatization with fatty acids in peptide and protein drug discovery","volume":"22","author":"Kurtzhals","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.bmc.2026.118633_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bmc.2026.118633_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview","volume":"35","author":"Correll","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.bmc.2026.118633_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drudis.2013.08.014","article-title":"Chemistry-enabled drug delivery (prodrugs): recent progress and challenges","volume":"19","author":"Clas","year":"2014","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bmc.2026.118633_bb0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1389200217666151210125831","article-title":"Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs","volume":"17","author":"Ragia","year":"2016","journal-title":"Curr Drug Metab"},{"issue":"3","key":"10.1016\/j.bmc.2026.118633_bb0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/pr.110.003459","article-title":"Prodrugs-from serendipity to rational design","volume":"63","author":"Huttunen","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2026.118633_bb0105","unstructured":"GLP-1\/GIP receptor co-agonist prodrugs and uses thereof. World Patent WO 2023\/139187 A1. July 27, 2023."},{"issue":"4","key":"10.1016\/j.bmc.2026.118633_bb0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10989-008-9152-1","article-title":"Investigation of the feasibility of an amide-based prodrug under physiological conditions","volume":"14","author":"De","year":"2008","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.bmc.2026.118633_bb0115","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1080\/09168451.2019.1659718","article-title":"Investigation of the formation mechanism of proline-containing cyclic dipeptide from the linear peptide","volume":"83","author":"Otsuka","year":"2019","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.bmc.2026.118633_bb0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/bip.21418","article-title":"Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1","volume":"94","author":"De","year":"2010","journal-title":"Biopolymers"},{"issue":"5","key":"10.1016\/j.bmc.2026.118633_bb0125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41429-023-00606-1","article-title":"Design, synthesis and antibacterial activity of novel colistin derivatives with thioether bond-mediated cyclic scaffold","volume":"76","author":"Li","year":"2023","journal-title":"J Antibiot (Tokyo)"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:01:42Z","timestamp":1779426102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S0968089626000891"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118633","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118633"}}